| NCT ID | NCT06512727 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florida |
| Condition | Musculoskeletal Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-05-07 |
| Primary Completion | 2027-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2025-05-07 with a primary completion date of 2027-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Chronic musculoskeletal pain (CMP), while a leading cause of physical disablement, is a neglected national health disparity issue in Black communities. The purpose of this study is to test a novel culturally congruent pain self-management intervention. A total of 120 persons aged 50-92, self-identifying as Black or African American having CMP will be invited to participate in this study. The primary outcome measured throughout this 3-year study is movement-evoked pain (MEP).
Eligibility Criteria
Inclusion Criteria: 1. Self-identify as being part of the Black American diaspora (Black/African American, Afro-Caribbean) 2. Age 50-92 years 3. Self-report chronic musculoskeletal pain (CMP) as defined as persistent or recurrent pain lasting 6 months or longer that arises as part of a disease or injurious process directly affecting bone(s), joint(s), muscle(s), or related soft tissue(s) 4. Self-report a chronic musculoskeletal condition (e.g., osteoarthritis, chronic low back pain) in at least one lower extremity joint (hip, knee, low back, or ankle pain) 5. Report chronic musculoskeletal symptoms: aching, stiffness, or swelling in a major lower extremity joint or low back on most days (4-5/7) of the week 6. Have (or be eligible for) a healthcare insurance plan in the state of Florida (Medicare, Medicaid, Medicare Advantage plans, Blue Cross/Blue Shield, Humana, Aetna, etc.) 7. Able to read, write, and understand English at sixth-grade level Exclusion Criteria: 1. Unwilling to be randomized to either study arm 2. Self-reported diagnosis of sickle cell disease or related thalassemias 3. History of major neurological event (e.g., stroke) or current neurological disease (e.g., Parkinson's disease, multiple sclerosis, epilepsy) 4. Major cardiovascular problem in the past 6 months that would cause shortness of breath and/or chest pain (e.g. myocardial infarction, coronary artery bypass graft, or valve replacement, pulmonary embolism or deep venous thrombosis) or uncontrolled Hypertension (Systolic Blood Pressure (SBP) \> 170 mmHg, Diastolic Blood Pressure (DBP) \> 90 mmHg) OR Hypotension (SBP \<90 mmHg, DBP \<60 mmHg) 5. Currently undergoing curative or palliative chemotherapy or radiation for active cancer 6. Severe physical impairment (e.g., a major activity of daily living disability requiring use of wheelchair as primary method of mobility, or unable to dress, bath, use the toilet, or transfer independently) 7. Serious mental health disorder requiring hospitalization within past 12 months 8. Severe sensory deficit (severe hearing loss or blindness)
Contact & Investigator
Staja Q Booker, PhD, RN
PRINCIPAL INVESTIGATOR
University of Florida
Frequently Asked Questions
Who can join the NCT06512727 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 92 Years, studying Musculoskeletal Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06512727 currently recruiting?
Yes, NCT06512727 is actively recruiting participants. Contact the research team at bookers@ufl.edu for enrollment information.
Where is the NCT06512727 trial being conducted?
This trial is being conducted at Gainesville, United States.
Who is sponsoring the NCT06512727 clinical trial?
NCT06512727 is sponsored by University of Florida. The principal investigator is Staja Q Booker, PhD, RN at University of Florida. The trial plans to enroll 120 participants.